Drug Type CAR-T |
Synonyms RB 1916, RB1916 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), IL-6 inhibitors(Interleukin-6 inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Refuge Biotechnologies, Inc.Startup |
Active Organization Refuge Biotechnologies, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | US | Refuge Biotechnologies, Inc.Startup | 28 Apr 2018 |